US Corporate Distress Financial Stress SEC Filings — October 26, 2026

Chapter 11 filed October 21, 2026 with up to $143M DIP financing under Cantor Fitzgerald; DIP liens rank senior on DIP Priority Collateral, signaling lender priority and a court-supervised restructuring path

Plan of Sale and Liquidation advancing toward NYSE delisting with assets moving to a Liquidating Trust; sale of 19 multifamily assets to a Cortland Partners affiliate defines the realizable value base for shareholders

Board retains the ability to terminate the Plan of Sale and Liquidation, leaving optionality if asset sale terms or market conditions change

Nasdaq granted 180 additional days, to April 19, 2027, to regain $1.00 bid price compliance, with no immediate effect on listing or trading in Class A common stock

NYSE suspending trading in EVEXW warrants for abnormally low selling price under Section 802.01D, while common stock (EVEX) remains listed and unaffected

Adequate protection payments to prepetition secured creditors, including cash interest and amortization on EUR Term Loan Claims held by Koch Equity Development, show secured creditors are being serviced during the case

Voluntary Chapter 11 petitions in Delaware Bankruptcy Court on October 21, 2026 with a distressed balance sheet and obligations to prepetition secured lenders and revolver holders

DIP liens subordinate to Carve Out and Adequate Protection Liens outside DIP Priority Collateral, which constrains recovery for unsecured and junior creditors

Liquidating distributions are not quantified in the filing and the company disclosed possible legal proceedings tied to the Cortland Partners asset sale, creating uncertainty for equity holders

Filing flags risks to REIT tax status during liquidation, which could affect the tax character of any distributions to shareholders

OTC trading after NYSE delisting is described as possible but not assured, reducing liquidity for remaining holders

Company was first notified of non-compliance on April 23, 2026, and the filing offers no assurance it will regain the $1.00 bid price within the extended period

NYSE characterized the EVEXW warrant price as abnormally low, and warrant holders face delisting with suspended trading ahead of the NYSE's SEC application

Court-supervised Chapter 11 with DIP financing in place may produce a defined reorganization path; secured creditors' priority position means value realization analysis should focus on the capital structure waterfall

Completion of the 19-asset sale and transfer to a Liquidating Trust may produce liquidating distributions to shareholders, with value realization timing dependent on trust administration

Extended cure period to April 19, 2027 gives the company time to regain the $1.00 minimum bid price, which could remove a delisting overhang if the share price recovers

Warrant delisting does not affect EVEX common stock, so the equity remains listed on the NYSE and the warrant overhang clears from the cap table

Of the four filings, one is a Chapter 11 (Getty), one is a liquidation-driven delisting (Elme), and two are exchange listing-compliance events (Zeo, Eve), showing that distress signals appear at multiple stages from listing deficiency to insolvency

The Getty DIP structure, with carve-outs, adequate protection payments, and senior DIP liens on priority collateral, illustrates how secured lenders are protected first in US Chapter 11 cases, which matters for unsecured creditor and equity recovery analysis

Both Zeo (Nasdaq Rule 5550(a)(2)) and Eve (NYSE Section 802.01D) show exchange rules forcing action on low-priced securities, and the timelines (180-day extensions, SEC application processes) define the window for remedy

Elme's voluntary dissolution through a Liquidating Trust represents a non-court alternative to Chapter 11 for a REIT with a defined asset sale, showing that orderly wind-downs are used in distress as well as formal bankruptcies

Monitor first-day and second-day hearings in the District of Delaware, DIP budget compliance against the $143M facility, and any sale or plan milestones following the October 21, 2026 petition date

Track the cadence of payments to Koch Equity Development and other prepetition secured lenders as a signal of creditor recovery priorities

Watch for the effective delisting date, the start of any OTC trading, and whether the Board exercises its right to terminate the Plan of Sale and Liquidation

Monitor for any legal proceedings tied to the 19-asset sale to a Cortland Partners affiliate, which could affect net liquidating distributions

Track the closing bid price of Class A common stock against the $1.00 threshold ahead of the April 19, 2027 compliance deadline

Watch for completion of the NYSE's SEC application and the effective date of warrant delisting, while confirming EVEX common stock continues to trade normally